nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—epithelium—cervical cancer	0.0255	0.0464	CbGeAlD
Pentoxifylline—NT5E—uterine cervix—cervical cancer	0.0253	0.046	CbGeAlD
Pentoxifylline—NT5E—Differentiation Pathway—WNT2—cervical cancer	0.0252	0.101	CbGpPWpGaD
Pentoxifylline—NT5E—decidua—cervical cancer	0.0241	0.0439	CbGeAlD
Pentoxifylline—NT5E—renal system—cervical cancer	0.0236	0.0431	CbGeAlD
Pentoxifylline—NT5E—endometrium—cervical cancer	0.0229	0.0416	CbGeAlD
Pentoxifylline—NT5E—mammalian vulva—cervical cancer	0.0221	0.0403	CbGeAlD
Pentoxifylline—NT5E—uterus—cervical cancer	0.0211	0.0384	CbGeAlD
Pentoxifylline—ADORA2B—decidua—cervical cancer	0.0206	0.0376	CbGeAlD
Pentoxifylline—NT5E—Differentiation Pathway—WNT5A—cervical cancer	0.0191	0.0762	CbGpPWpGaD
Pentoxifylline—NT5E—female reproductive system—cervical cancer	0.0189	0.0345	CbGeAlD
Pentoxifylline—ADORA2B—mammalian vulva—cervical cancer	0.0189	0.0345	CbGeAlD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.0184	0.0736	CbGpPWpGaD
Pentoxifylline—PDE4A—decidua—cervical cancer	0.0184	0.0335	CbGeAlD
Pentoxifylline—NT5E—female gonad—cervical cancer	0.0172	0.0314	CbGeAlD
Pentoxifylline—NT5E—vagina—cervical cancer	0.0171	0.0312	CbGeAlD
Pentoxifylline—PDE5A—epithelium—cervical cancer	0.0165	0.0301	CbGeAlD
Pentoxifylline—PDE5A—uterine cervix—cervical cancer	0.0164	0.0299	CbGeAlD
Pentoxifylline—PDE5A—renal system—cervical cancer	0.0153	0.0279	CbGeAlD
Pentoxifylline—Heartburn—Topotecan—cervical cancer	0.0148	0.0741	CcSEcCtD
Pentoxifylline—ADORA2B—vagina—cervical cancer	0.0147	0.0267	CbGeAlD
Pentoxifylline—ADORA1—renal system—cervical cancer	0.0145	0.0265	CbGeAlD
Pentoxifylline—ADORA2A—female reproductive system—cervical cancer	0.0135	0.0246	CbGeAlD
Pentoxifylline—PDE4A—female gonad—cervical cancer	0.0132	0.024	CbGeAlD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—PIAS3—cervical cancer	0.0125	0.0497	CbGpPWpGaD
Pentoxifylline—PDE5A—female reproductive system—cervical cancer	0.0123	0.0224	CbGeAlD
Pentoxifylline—ADORA1—female reproductive system—cervical cancer	0.0117	0.0212	CbGeAlD
Pentoxifylline—PDE4B—uterine cervix—cervical cancer	0.0115	0.0209	CbGeAlD
Pentoxifylline—PDE5A—female gonad—cervical cancer	0.0112	0.0204	CbGeAlD
Pentoxifylline—PDE5A—vagina—cervical cancer	0.0111	0.0202	CbGeAlD
Pentoxifylline—NT5E—lymph node—cervical cancer	0.0111	0.0202	CbGeAlD
Pentoxifylline—PDE4B—decidua—cervical cancer	0.011	0.02	CbGeAlD
Pentoxifylline—ADORA1—vagina—cervical cancer	0.0105	0.0192	CbGeAlD
Pentoxifylline—PDE4B—endometrium—cervical cancer	0.0104	0.0189	CbGeAlD
Pentoxifylline—PDE4B—mammalian vulva—cervical cancer	0.0101	0.0183	CbGeAlD
Pentoxifylline—Ear pain—Topotecan—cervical cancer	0.00869	0.0434	CcSEcCtD
Pentoxifylline—PDE4B—female reproductive system—cervical cancer	0.00862	0.0157	CbGeAlD
Pentoxifylline—PDE4A—lymph node—cervical cancer	0.00846	0.0154	CbGeAlD
Pentoxifylline—NT5E—Differentiation Pathway—NOTCH1—cervical cancer	0.0083	0.0331	CbGpPWpGaD
Pentoxifylline—PDE4B—female gonad—cervical cancer	0.00784	0.0143	CbGeAlD
Pentoxifylline—PDE4B—vagina—cervical cancer	0.0078	0.0142	CbGeAlD
Pentoxifylline—Anaphylactoid reaction—Topotecan—cervical cancer	0.00766	0.0383	CcSEcCtD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—TAAR6—cervical cancer	0.00764	0.0305	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.00747	0.0298	CbGpPWpGaD
Pentoxifylline—PDE5A—lymph node—cervical cancer	0.00719	0.0131	CbGeAlD
Pentoxifylline—PDE4A—G alpha (s) signalling events—TAAR6—cervical cancer	0.00694	0.0277	CbGpPWpGaD
Pentoxifylline—ADORA1—lymph node—cervical cancer	0.00682	0.0124	CbGeAlD
Pentoxifylline—CYP1A2—renal system—cervical cancer	0.00661	0.012	CbGeAlD
Pentoxifylline—PDE4B—G alpha (s) signalling events—TAAR6—cervical cancer	0.00642	0.0256	CbGpPWpGaD
Pentoxifylline—Pancytopenia—Topotecan—cervical cancer	0.00609	0.0304	CcSEcCtD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00599	0.0239	CbGpPWpGaD
Pentoxifylline—Infestation—Topotecan—cervical cancer	0.00572	0.0285	CcSEcCtD
Pentoxifylline—Infestation NOS—Topotecan—cervical cancer	0.00572	0.0285	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—SERPIND1—cervical cancer	0.00561	0.0224	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—GP6—cervical cancer	0.00561	0.0224	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—AKAP13—cervical cancer	0.00554	0.0221	CbGpPWpGaD
Pentoxifylline—Sweating—Topotecan—cervical cancer	0.00548	0.0274	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Topotecan—cervical cancer	0.00541	0.027	CcSEcCtD
Pentoxifylline—Epistaxis—Topotecan—cervical cancer	0.00539	0.0269	CcSEcCtD
Pentoxifylline—Haemoglobin—Topotecan—cervical cancer	0.00516	0.0258	CcSEcCtD
Pentoxifylline—Haemorrhage—Topotecan—cervical cancer	0.00513	0.0256	CcSEcCtD
Pentoxifylline—PDE4B—lymph node—cervical cancer	0.00504	0.00918	CbGeAlD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—TAAR6—cervical cancer	0.00502	0.02	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—GP5—cervical cancer	0.00491	0.0196	CbGpPWpGaD
Pentoxifylline—Immune system disorder—Topotecan—cervical cancer	0.00463	0.0231	CcSEcCtD
Pentoxifylline—Back pain—Topotecan—cervical cancer	0.00432	0.0216	CcSEcCtD
Pentoxifylline—Muscle spasms—Topotecan—cervical cancer	0.00429	0.0214	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Topotecan—cervical cancer	0.00414	0.0207	CcSEcCtD
Pentoxifylline—Anaemia—Topotecan—cervical cancer	0.00413	0.0206	CcSEcCtD
Pentoxifylline—Angioedema—Topotecan—cervical cancer	0.00408	0.0204	CcSEcCtD
Pentoxifylline—Malaise—Topotecan—cervical cancer	0.00403	0.0201	CcSEcCtD
Pentoxifylline—Leukopenia—Topotecan—cervical cancer	0.004	0.02	CcSEcCtD
Pentoxifylline—Chest pain—Topotecan—cervical cancer	0.0038	0.019	CcSEcCtD
Pentoxifylline—Myalgia—Topotecan—cervical cancer	0.0038	0.019	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00378	0.0189	CcSEcCtD
Pentoxifylline—Discomfort—Topotecan—cervical cancer	0.00376	0.0188	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Topotecan—cervical cancer	0.00365	0.0182	CcSEcCtD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00364	0.0145	CbGpPWpGaD
Pentoxifylline—Infection—Topotecan—cervical cancer	0.00362	0.0181	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Topotecan—cervical cancer	0.00357	0.0178	CcSEcCtD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—HES1—cervical cancer	0.00355	0.0142	CbGpPWpGaD
Pentoxifylline—Skin disorder—Topotecan—cervical cancer	0.00354	0.0177	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Topotecan—cervical cancer	0.00352	0.0176	CcSEcCtD
Pentoxifylline—Anorexia—Topotecan—cervical cancer	0.00347	0.0174	CcSEcCtD
Pentoxifylline—ADORA1—Circadian rythm related genes—UBE3A—cervical cancer	0.00339	0.0135	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00332	0.0166	CcSEcCtD
Pentoxifylline—Dyspnoea—Topotecan—cervical cancer	0.00325	0.0162	CcSEcCtD
Pentoxifylline—Dyspepsia—Topotecan—cervical cancer	0.00321	0.016	CcSEcCtD
Pentoxifylline—Decreased appetite—Topotecan—cervical cancer	0.00317	0.0158	CcSEcCtD
Pentoxifylline—Constipation—Topotecan—cervical cancer	0.00312	0.0156	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0031	0.0124	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Topotecan—cervical cancer	0.003	0.015	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Topotecan—cervical cancer	0.00298	0.0149	CcSEcCtD
Pentoxifylline—Urticaria—Topotecan—cervical cancer	0.0029	0.0145	CcSEcCtD
Pentoxifylline—Abdominal pain—Topotecan—cervical cancer	0.00288	0.0144	CcSEcCtD
Pentoxifylline—Body temperature increased—Topotecan—cervical cancer	0.00288	0.0144	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—TAAR6—cervical cancer	0.00277	0.0111	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Topotecan—cervical cancer	0.00269	0.0134	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—UBE3A—cervical cancer	0.00262	0.0105	CbGpPWpGaD
Pentoxifylline—Asthenia—Topotecan—cervical cancer	0.00262	0.0131	CcSEcCtD
Pentoxifylline—Pruritus—Topotecan—cervical cancer	0.00258	0.0129	CcSEcCtD
Pentoxifylline—Diarrhoea—Topotecan—cervical cancer	0.00249	0.0125	CcSEcCtD
Pentoxifylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00246	0.00981	CbGpPWpGaD
Pentoxifylline—Dizziness—Topotecan—cervical cancer	0.00241	0.012	CcSEcCtD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00239	0.00954	CbGpPWpGaD
Pentoxifylline—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.00237	0.00944	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—TAAR6—cervical cancer	0.00236	0.00941	CbGpPWpGaD
Pentoxifylline—Vomiting—Topotecan—cervical cancer	0.00232	0.0116	CcSEcCtD
Pentoxifylline—Rash—Topotecan—cervical cancer	0.0023	0.0115	CcSEcCtD
Pentoxifylline—Dermatitis—Topotecan—cervical cancer	0.0023	0.0115	CcSEcCtD
Pentoxifylline—Headache—Topotecan—cervical cancer	0.00228	0.0114	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—WNT2—cervical cancer	0.00217	0.00864	CbGpPWpGaD
Pentoxifylline—Nausea—Topotecan—cervical cancer	0.00217	0.0108	CcSEcCtD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CD4—cervical cancer	0.00201	0.008	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—WNT2—cervical cancer	0.00184	0.00735	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—TAAR6—cervical cancer	0.00182	0.00727	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKAP13—cervical cancer	0.00176	0.00703	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—WNT5A—cervical cancer	0.00164	0.00655	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TAAR6—cervical cancer	0.00157	0.00626	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CA9—cervical cancer	0.00147	0.00585	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TAAR6—cervical cancer	0.00142	0.00568	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TAAR6—cervical cancer	0.00142	0.00568	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—WNT2—cervical cancer	0.00142	0.00567	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—WNT5A—cervical cancer	0.0014	0.00557	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TAAR6—cervical cancer	0.00133	0.00532	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TAAR6—cervical cancer	0.00132	0.00526	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TAAR6—cervical cancer	0.00129	0.00516	CbGpPWpGaD
Pentoxifylline—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00126	0.00502	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TAAR6—cervical cancer	0.00121	0.00483	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TAAR6—cervical cancer	0.0012	0.00477	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—WNT2—cervical cancer	0.00111	0.00444	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—WNT5A—cervical cancer	0.00108	0.0043	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKAP13—cervical cancer	0.00107	0.00429	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00105	0.00418	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00103	0.00411	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—WNT2—cervical cancer	0.00101	0.00403	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKAP13—cervical cancer	0.000976	0.00389	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKAP13—cervical cancer	0.000976	0.00389	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—WNT2—cervical cancer	0.000945	0.00377	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TAAR6—cervical cancer	0.000935	0.00373	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—WNT2—cervical cancer	0.000934	0.00373	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.000915	0.00365	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKAP13—cervical cancer	0.000914	0.00365	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKAP13—cervical cancer	0.000903	0.0036	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKAP13—cervical cancer	0.000886	0.00354	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—WNT5A—cervical cancer	0.000842	0.00336	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAAR6—cervical cancer	0.000841	0.00336	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKAP13—cervical cancer	0.00083	0.00331	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKAP13—cervical cancer	0.00082	0.00327	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—WNT5A—cervical cancer	0.000765	0.00305	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAAR6—cervical cancer	0.000764	0.00305	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—WNT2—cervical cancer	0.00073	0.00291	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—WNT5A—cervical cancer	0.000716	0.00286	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAAR6—cervical cancer	0.000715	0.00285	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—WNT5A—cervical cancer	0.000708	0.00282	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAAR6—cervical cancer	0.000707	0.00282	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000705	0.00282	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FGFR3—cervical cancer	0.000704	0.00281	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WNT2—cervical cancer	0.000657	0.00262	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000644	0.00257	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000641	0.00256	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WNT2—cervical cancer	0.000596	0.00238	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MTHFR—cervical cancer	0.000595	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKAP13—cervical cancer	0.000576	0.0023	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WNT2—cervical cancer	0.000558	0.00223	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000553	0.00221	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAAR6—cervical cancer	0.000552	0.0022	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WNT2—cervical cancer	0.000552	0.0022	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKAP13—cervical cancer	0.000523	0.00209	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—cervical cancer	0.000501	0.002	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WNT5A—cervical cancer	0.000498	0.00199	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000497	0.00199	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MTOR—cervical cancer	0.000495	0.00198	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKAP13—cervical cancer	0.00049	0.00196	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKAP13—cervical cancer	0.000484	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CASP3—cervical cancer	0.000455	0.00182	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000452	0.0018	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WNT5A—cervical cancer	0.000452	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WNT2—cervical cancer	0.000431	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WNT5A—cervical cancer	0.000423	0.00169	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—cervical cancer	0.000422	0.00169	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WNT5A—cervical cancer	0.000418	0.00167	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000416	0.00166	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000416	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—cervical cancer	0.000387	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—STAT3—cervical cancer	0.000383	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKAP13—cervical cancer	0.000378	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000349	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—cervical cancer	0.000348	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WNT5A—cervical cancer	0.000327	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH2—cervical cancer	0.000317	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH2—cervical cancer	0.000297	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH2—cervical cancer	0.000293	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HES1—cervical cancer	0.000286	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HES1—cervical cancer	0.00026	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TERT—cervical cancer	0.000251	0.001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HES1—cervical cancer	0.000243	0.000972	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HES1—cervical cancer	0.000241	0.00096	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGFR3—cervical cancer	0.00023	0.000919	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000229	0.000915	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TERT—cervical cancer	0.000228	0.000909	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000216	0.000863	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TERT—cervical cancer	0.000213	0.000851	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TERT—cervical cancer	0.000211	0.000841	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGFR3—cervical cancer	0.000209	0.000834	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—cervical cancer	0.000196	0.000783	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGFR3—cervical cancer	0.000196	0.000781	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGFR3—cervical cancer	0.000193	0.000772	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—cervical cancer	0.000193	0.000769	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES1—cervical cancer	0.000188	0.00075	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—cervical cancer	0.000184	0.000733	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—cervical cancer	0.000182	0.000725	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—cervical cancer	0.000175	0.000698	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—cervical cancer	0.000165	0.000657	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—cervical cancer	0.000164	0.000653	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—cervical cancer	0.000162	0.000646	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—cervical cancer	0.000162	0.000646	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGFR3—cervical cancer	0.000151	0.000603	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—cervical cancer	0.000149	0.000595	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—cervical cancer	0.000147	0.000587	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—cervical cancer	0.000144	0.000573	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000142	0.000566	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—cervical cancer	0.000138	0.00055	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—cervical cancer	0.000136	0.000543	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—cervical cancer	0.000135	0.00054	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA9—cervical cancer	0.000135	0.000539	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—cervical cancer	0.00013	0.00052	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—cervical cancer	0.000127	0.000506	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—cervical cancer	0.000126	0.000505	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—cervical cancer	0.000125	0.0005	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—cervical cancer	0.000125	0.0005	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—cervical cancer	0.000122	0.000487	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—cervical cancer	0.000121	0.000481	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—cervical cancer	0.000114	0.000454	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—cervical cancer	0.000114	0.000454	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—cervical cancer	0.000106	0.000425	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—cervical cancer	0.000106	0.000424	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—cervical cancer	0.000105	0.00042	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—cervical cancer	0.000103	0.000412	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—cervical cancer	9.78e-05	0.00039	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—cervical cancer	9.67e-05	0.000386	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—cervical cancer	9.56e-05	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—cervical cancer	9.55e-05	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—cervical cancer	9.43e-05	0.000376	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—cervical cancer	8.67e-05	0.000346	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—cervical cancer	8.22e-05	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—cervical cancer	8.12e-05	0.000324	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—cervical cancer	8.03e-05	0.00032	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—cervical cancer	7.47e-05	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—cervical cancer	6.27e-05	0.00025	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—cervical cancer	5.48e-05	0.000219	CbGpPWpGaD
